Regeneron Pharmaceuticals
REGN
#282
Rank
NZ$140.07 B
Marketcap
NZ$1,322
Share price
-1.18%
Change (1 day)
3.76%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: NZ$140.07 Billion

As of January 2026 Regeneron Pharmaceuticals has a market cap of NZ$140.07 Billion. This makes Regeneron Pharmaceuticals the world's 282th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$140.07 B-2.49%
2025NZ$143.65 B3.49%
2024NZ$138.81 B-8.26%
2023NZ$151.30 B22.26%
2022NZ$123.75 B24.46%
2021NZ$99.43 B39.17%
2020NZ$71.44 B16.21%
2019NZ$61.48 B1.29%
2018NZ$60.69 B6.72%
2017NZ$56.87 B1.76%
2016NZ$55.89 B-32.66%
2015NZ$83.00 B54.77%
2014NZ$53.63 B60.63%
2013NZ$33.38 B65.03%
2012NZ$20.23 B207.72%
2011NZ$6.57 B72.79%
2010NZ$3.80 B40.93%
2009NZ$2.70 B7.15%
2008NZ$2.51 B1.36%
2007NZ$2.48 B33.43%
2006NZ$1.86 B41.91%
2005NZ$1.31 B82.1%
2004NZ$0.72 B-42.66%
2003NZ$1.25 B-20.12%
2002NZ$1.57 B-47.21%
2001NZ$2.98 B1.82%
2000NZ$2.92 B281.93%
1999NZ$0.76 B76.61%
1998NZ$0.43 B-4.87%
1997NZ$0.45 B-22.14%
1996NZ$0.58 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Regeneron Pharmaceuticals was reported to be:

NZ$138.90 Billion
by Nasdaq info icon info icon
NZ$140.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$304.11 B 117.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$85.11 B-39.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$45.55 B-67.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$896.42 B 539.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$473.20 B 237.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$199.14 B 42.17%๐Ÿ‡ซ๐Ÿ‡ท France